Richard S. Ungerleider

Hematology | Oncology
22 Bayside Dr
Atlantic Highlands, NJ 07716

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.

Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors.

Journal: Investigational new drugs
Published: August 03, 2021
Showing 1-1 of 1

Last Updated: 09/26/2026